• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病例报告:通过三阶段根治性同步放化疗实现长期完全缓解的转移性胃鳞状细胞癌

Case report: Metastatic gastric squamous cell carcinoma with long duration of complete response via three-staged radical concurrent chemoradiotherapy.

作者信息

Zang Rui, Zheng Linpeng, Xie Lijiao, Zhong Liangzhi, Sun Jianguo

机构信息

Department of Oncology, Xinqiao Hospital, Army Medical University, Chongqing, 400037, China.

出版信息

Heliyon. 2024 Oct 18;10(21):e39266. doi: 10.1016/j.heliyon.2024.e39266. eCollection 2024 Nov 15.

DOI:10.1016/j.heliyon.2024.e39266
PMID:39553676
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11565023/
Abstract

INTRODUCTION

Primary Gastric Squamous Cell Carcinoma (GSCC), especially in late-stage, is a very rare pathological type with poor prognosis. We report a long duration of Complete Response (CR) of GSCC case with multiple metastases by an elaborate three-staged radical Concurrent Chemoradiotherapy (CCRT).

CASE PRESENTATION

A 36-year-old male suffered from weakness and melena, and then was diagnosed as primary GSCC with cT3N3M1, Stage IV. According to the characteristics of multiple lymph nodes metastases at supraclavicular, perigastric and pelvic regions, an individualized therapeutic strategy of three-staged radical CCRT was elaborately designed and cautiously performed even after the accidental massive hemorrhage of the upper digestive tract under the guidance of a multidisciplinary team. A long-term CR was achieved, with Progression Free Survival (PFS) and Overall Survival (OS) of 74 months by the last follow-up. The case with multiple metastases was radically treated as local advanced disease with complete success.

CONCLUSION

Patient with stage IV mGSCC who has achieved CR and unexpected long-term PFS and OS through CCRT due to precise judgement and well-designed individualized therapy. The immunomodulatory effect of radiation therapy on the tumor microenvironment may be a potential mechanism affecting treatment efficacy.

摘要

引言

原发性胃鳞状细胞癌(GSCC),尤其是晚期,是一种非常罕见的病理类型,预后较差。我们报告了一例通过精心设计的三阶段根治性同步放化疗(CCRT)实现长期完全缓解(CR)的GSCC多发转移病例。

病例介绍

一名36岁男性出现乏力和黑便,随后被诊断为原发性GSCC,cT3N3M1,IV期。根据锁骨上、胃周和盆腔区域多发淋巴结转移的特点,精心设计并谨慎实施了三阶段根治性CCRT个体化治疗策略,即使在多学科团队指导下上消化道意外大出血后仍继续进行。实现了长期CR,末次随访时无进展生存期(PFS)和总生存期(OS)均为74个月。该多发转移病例作为局部晚期疾病得到了根治性治疗并取得圆满成功。

结论

IV期mGSCC患者通过精确判断和精心设计的个体化治疗,经CCRT实现了CR以及意外的长期PFS和OS。放射治疗对肿瘤微环境的免疫调节作用可能是影响治疗效果的潜在机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0378/11565023/95055179fbb5/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0378/11565023/6a4f64bbf951/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0378/11565023/4d014dc159e3/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0378/11565023/8a9a342d4535/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0378/11565023/95055179fbb5/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0378/11565023/6a4f64bbf951/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0378/11565023/4d014dc159e3/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0378/11565023/8a9a342d4535/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0378/11565023/95055179fbb5/gr4.jpg

相似文献

1
Case report: Metastatic gastric squamous cell carcinoma with long duration of complete response via three-staged radical concurrent chemoradiotherapy.病例报告:通过三阶段根治性同步放化疗实现长期完全缓解的转移性胃鳞状细胞癌
Heliyon. 2024 Oct 18;10(21):e39266. doi: 10.1016/j.heliyon.2024.e39266. eCollection 2024 Nov 15.
2
Sintilimab as maintenance treatment for local/regional recurrent esophageal squamous carcinoma after concurrent chemoradiotherapy: a single-arm Ib/II phase study.信迪利单抗作为同期放化疗后局部/区域性复发性食管鳞癌维持治疗的单臂 Ib/II 期研究。
Front Immunol. 2023 May 31;14:1193394. doi: 10.3389/fimmu.2023.1193394. eCollection 2023.
3
Role of primary tumor volume and metastatic lymph node volume in response to curative effect of definitive radiotherapy for locally advanced head and neck cancer.原发肿瘤体积和转移淋巴结体积在局部晚期头颈癌根治性放疗疗效中的作用。
Eur J Med Res. 2024 Feb 4;29(1):98. doi: 10.1186/s40001-024-01691-0.
4
Induction immunotherapy plus chemotherapy followed by definitive chemoradiation therapy in locally advanced esophageal squamous cell carcinoma: a propensity-score matched study.诱导免疫治疗联合化疗后行根治性放化疗治疗局部晚期食管鳞癌:一项倾向评分匹配研究。
Cancer Immunol Immunother. 2024 Feb 16;73(3):55. doi: 10.1007/s00262-024-03649-x.
5
Three-dimensional conformal radiotherapy with concurrent chemotherapy for postoperative recurrence of esophageal squamous cell carcinoma: clinical efficacy and failure pattern.三维适形放疗同步化疗治疗食管鳞癌术后复发的临床疗效和失败模式。
Radiat Oncol. 2013 Oct 18;8:241. doi: 10.1186/1748-717X-8-241.
6
[Curative effect analysis of postoperative concurrent chemoradiotherapy on early-stage cervical cancer patients with intermediate-risk factors].[术后同步放化疗对具有中危因素的早期宫颈癌患者的疗效分析]
Zhonghua Zhong Liu Za Zhi. 2018 Jun 23;40(6):462-466. doi: 10.3760/cma.j.issn.0253-3766.2018.06.012.
7
Outcome and toxicity of radical radiotherapy or concurrent Chemoradiotherapy for elderly cervical cancer women.老年宫颈癌女性接受根治性放疗或同步放化疗的疗效与毒性
BMC Cancer. 2017 Aug 1;17(1):510. doi: 10.1186/s12885-017-3503-2.
8
[Outcomes and prognostic factors of distant metastasis in patients with advanced cervical squamous cell carcinoma treated with concurrent chemoradiotherapy].[同步放化疗治疗晚期宫颈鳞状细胞癌患者远处转移的结局及预后因素]
Zhonghua Fu Chan Ke Za Zhi. 2015 Feb;50(2):125-30.
9
Efficacy and safety of PD-1 inhibitor combined with concurrent chemoradiotherapy in locally advanced cervical cancer with pelvic and/or para-aortic lymph node metastases: a retrospective cohort study.PD-1 抑制剂联合同期放化疗治疗盆腔和/或腹主动脉旁淋巴结转移的局部晚期宫颈癌的疗效和安全性:一项回顾性队列研究。
Chin Clin Oncol. 2023 Aug;12(4):38. doi: 10.21037/cco-23-70.
10
[Outcomes and prognostic factors of advanced squamous cervical cancer after concurrent chemoradiotherapy].[同步放化疗后晚期宫颈鳞癌的疗效及预后因素]
Zhonghua Fu Chan Ke Za Zhi. 2014 May;49(5):348-54.

本文引用的文献

1
First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial.一线纳武利尤单抗联合化疗与单纯化疗治疗晚期胃癌、胃食管交界癌和食管腺癌(CheckMate 649):一项随机、开放标签的3期试验。
Lancet. 2021 Jul 3;398(10294):27-40. doi: 10.1016/S0140-6736(21)00797-2. Epub 2021 Jun 5.
2
Primary gastric squamous cell carcinoma presenting as a large submucosal mass: A case report and literature review.以巨大黏膜下肿块为表现的原发性胃鳞状细胞癌:1例报告及文献复习
Medicine (Baltimore). 2020 Sep 4;99(36):e22125. doi: 10.1097/MD.0000000000022125.
3
Metastatic Primary Gastric Squamous Cell Carcinoma: An Uncommon Presentation of a Rare Malignancy.
转移性原发性胃鳞状细胞癌:一种罕见恶性肿瘤的不常见表现。
Case Rep Gastrointest Med. 2019 Oct 7;2019:5305023. doi: 10.1155/2019/5305023. eCollection 2019.
4
A type of neoplasia deadlier than gastric adenocarcinoma? Report of a case of primary gastric squamous cell carcinoma.一种比胃腺癌更致命的肿瘤?原发性胃鳞癌 1 例报告。
World J Surg Oncol. 2019 Jun 29;17(1):113. doi: 10.1186/s12957-019-1657-x.
5
The clinicopathological features and prognostic factors of gastric squamous cell carcinoma.胃鳞状细胞癌的临床病理特征及预后因素
Medicine (Baltimore). 2016 Aug;95(34):e4720. doi: 10.1097/MD.0000000000004720.
6
Primary squamous cell carcinoma of the stomach: a case report and literature review.胃原发性鳞状细胞癌:一例报告及文献复习
Int J Clin Exp Pathol. 2015 Aug 1;8(8):9667-71. eCollection 2015.